Andra språk AbbVie Inc.

Aktier

ABBV

US00287Y1091

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22:00:02 09.07.2025			5-dagars förändring	Förändring 1 jan.
190,62 ^USD	+0,45 %		−0,07 %	+7,27 %

09.07.	Stora affärer med amerikanska läkemedels- och bioteknikbolag under det senaste decenniet	RE
09.07.	Hälsoronden: Experimentellt Bayer-läkemedel lindrar klimakterieliknande besvär vid bröstcancerbehandling	RE

Andra språk

Major deals involving U.S. drugmakers and biotechs over the past decade	09.07.
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	09.07.
Company earnings: key dates for next week	09.07.
MÄRKTE USA/Trump verhindert Erholung der Börsen	08.07.
AbbVie's Tax Triumph: Breaking Free From Capital Loss Limitations	02.07.
Organon abandons endometriosis pain drug development after trial failure	02.07.
Global markets live: Apple, Google, Boeing, Renault, Macquarie…	01.07.
All-Time Highs, All-Time Uncertainty	01.07.
Health Care Up as Budget Bill Fears Ease -- Health Care Roundup	30.06.
AbbVie Inc.(NYSE:ABBV) dropped from Russell 1000 Value-Defensive Index	30.06.
Sector Update: Health Care Stocks Higher Late Afternoon	30.06.
Sector Update: Health Care Stocks Advance Monday Afternoon	30.06.
AbbVie to buy Capstan for up to $2.1 billion in immunology push	30.06.
AbbVie to buy Capstan for up to $2.1 billion in immunology push	30.06.
Top Midday Stories: Hewlett Packard, Juniper Settle Antitrust Suit With DOJ; Home Depot Unit Acquires GMS for $5.5 Billion	30.06.
AbbVie: agreement to acquire Capstan	30.06.
AbbVie Unit Allergan Says US FDA Accepts For Review Premarket Approval Application For Intradermal Injection	30.06.
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion	30.06.
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion	30.06.
Deals of the Day-Mergers and acquisitions	30.06.
AbbVie Agrees to Acquire Capstan Therapeutics for $2.1 Billion in Cash	30.06.
AbbVie to buy Capstan Therapeutics for up to $2.1 billion	30.06.
AbbVie Inc.(NYSE:ABBV) dropped from Russell 3000E Value Index	30.06.
AbbVie Inc.(NYSE:ABBV) dropped from Russell Top 200 Value Index	30.06.
AbbVie to Host Second-Quarter 2025 Earnings Conference Call	30.06.

Inga resultat för denna sökning

Alla nyheter Analytikers rekommendationer Viktiga händelser Insiders Transkriptioner Pressmeddelanden Officiella publikationer Andra språk Handelsidéer MarketScreener Artiklar MarketScreener Analyser

Andra språk AbbVie Inc.

Aktier

ABBV

US00287Y1091

Farmaceutiska produkter

Andra språk

Filter